These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 14603058)
1. Three-dimensional reconstruction of immunolabeled neuromuscular junctions in the human thyroarytenoid muscle. Sheppert AD; Spirou GA; Berrebi AS; Garnett JD Laryngoscope; 2003 Nov; 113(11):1973-6. PubMed ID: 14603058 [TBL] [Abstract][Full Text] [Related]
2. Three-dimensional computer reconstruction of the distribution of neuromuscular junctions in the thyroarytenoid muscle. Rosen M; Malmgren LT; Gacek RR Ann Otol Rhinol Laryngol; 1983; 92(5 Pt 1):424-9. PubMed ID: 6625438 [TBL] [Abstract][Full Text] [Related]
7. Transoral electromyographic recordings in botulinum toxin-injected rat larynges. Inagi K; Rodriquez AA; Ford CN; Heisey DM Ann Otol Rhinol Laryngol; 1997 Nov; 106(11):956-64. PubMed ID: 9373087 [TBL] [Abstract][Full Text] [Related]
8. The treatment of essential voice tremor with botulinum toxin A: a longitudinal case report. Warrick P; Dromey C; Irish J; Durkin L J Voice; 2000 Sep; 14(3):410-21. PubMed ID: 11021508 [TBL] [Abstract][Full Text] [Related]
9. [Effect of cricothyroid and thyroarytenoid muscle botulinum toxin injection on patients with dyspnea caused by bilateral recurrent laryngeal nerve paresis]. Xu XL; Lai JM; Qiu T; Ma YL; Jiao YC; Zhuang PY Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):375-380. PubMed ID: 29764020 [No Abstract] [Full Text] [Related]
10. [Treatment of spasmodic dysphonia with botulinum toxin]. Klap P; Marion MH; Perrin A; Fresnel-Elbaz E Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624 [TBL] [Abstract][Full Text] [Related]
11. Botox treatment in adductor spasmodic dysphonia: a meta-analysis. Boutsen F; Cannito MP; Taylor M; Bender B J Speech Lang Hear Res; 2002 Jun; 45(3):469-81. PubMed ID: 12069000 [TBL] [Abstract][Full Text] [Related]
12. The effect of patient factors on response outcomes to Botox treatment of spasmodic dysphonia. Lundy DS; Lu FL; Casiano RR; Xue JW J Voice; 1998 Dec; 12(4):460-6. PubMed ID: 9988033 [TBL] [Abstract][Full Text] [Related]
13. Laryngeal dystonia: case report and treatment with botulinum toxin. Santos VJ; Mattioli FM; Mattioli WM; Daniel RJ; Cruz VP Braz J Otorhinolaryngol; 2006; 72(3):425-7. PubMed ID: 17119783 [TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin injection and airflow stability in spasmodic dysphonia. Cantarella G; Berlusconi A; Maraschi B; Ghio A; Barbieri S Otolaryngol Head Neck Surg; 2006 Mar; 134(3):419-23. PubMed ID: 16500438 [TBL] [Abstract][Full Text] [Related]
15. Three-dimensional computer reconstruction of the neuromuscular junction distribution in the human posterior cricoarytenoid muscle. Gambino DR; Malmgren LT; Gacek RR Laryngoscope; 1985 May; 95(5):556-60. PubMed ID: 3990485 [TBL] [Abstract][Full Text] [Related]
17. Effect of Botulinum Toxin and Surgery among Spasmodic Dysphonia Patients. van Esch BF; Wegner I; Stegeman I; Grolman W Otolaryngol Head Neck Surg; 2017 Feb; 156(2):238-254. PubMed ID: 27803079 [TBL] [Abstract][Full Text] [Related]
18. Unilateral versus bilateral injections of botulinum toxin in patients with adductor spasmodic dysphonia. Bielamowicz S; Stager SV; Badillo A; Godlewski A J Voice; 2002 Mar; 16(1):117-23. PubMed ID: 12002878 [TBL] [Abstract][Full Text] [Related]
19. Tremor laryngeal dystonia: treatment of the lateral cricoarytenoid muscle. Maronian NC; Waugh PF; Robinson L; Hillel AD Ann Otol Rhinol Laryngol; 2004 May; 113(5):349-55. PubMed ID: 15174760 [TBL] [Abstract][Full Text] [Related]
20. Gender differences in onabotulinum toxin A dosing for adductor spasmodic dysphonia. Lerner MZ; Lerner BA; Patel AA; Blitzer A Laryngoscope; 2017 May; 127(5):1131-1134. PubMed ID: 27633917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]